1. Abeillon-du PJ, Chikh K, Bossard N, Bretones P, Gaucherand P, Claris O, et al. Predictive value of maternal second-generation thyroid-binding inhibitory immunoglobulin assay for neonatal autoimmune hyperthyroidism. Eur J Endocrinol. 2014;171(4):451–60.
2. Adams DD, Purve HD. Abnormal responses in the assay of thyrotropin. Proc Univ Otago Med Sch. 1956;34:11–2.
3. Adler TR, Beall GN, Curd JG, Heiner DC, Sabharwal UK. Studies of complement activation and IgG subclass restriction of anti-thyroglobulin. Clin Exp Immunol. 1984;56(2):383–9.
4. Ajjan RA, Weetman AP. Techniques to quantify TSH receptor antibodies. Nat Clin Pract Endocrinol Metab. 2008;4(8):461–8.
5. Ajjan RA, Findlay C, Metcalfe RA, Watson PF, Crisp M, Ludgate M, et al. The modulation of the human sodium iodide symporter activity by Graves’ disease sera. J Clin Endocrinol Metab. 1998;83(4):1217–21.